Expression of transforming growth factors beta-I, beta 2 and beta 3 in human bladder carcinomas
1997

Transforming Growth Factors in Bladder Cancer

Sample size: 45 publication Evidence: moderate

Author Information

Author(s): IE Eder, A Stenzl, A Hobisch, MV Cronauer, G Bartsch, H Klocker

Primary Institution: Department of Urology, University of Innsbruck

Hypothesis

Do elevated serum levels of TGF-β correlate with increased TGF-β expression in bladder tumor tissue?

Conclusion

There is no correlation between TGF-β serum levels and TGF-β expression in tumor tissue in bladder cancer.

Supporting Evidence

  • TGF-β1 protein levels were significantly higher in superficial tumors compared to normal urothelium.
  • Reduced expression of TGF-β mRNA was found in bladder tumor samples compared with normal urothelium.
  • High serum levels of TGF-β1 in patients with invasive bladder carcinomas correlate with low protein levels in tumor tissue.

Takeaway

The study looked at how a protein related to cancer behaves in bladder tumors, and found that higher levels in the blood don't match levels in the tumors themselves.

Methodology

The study involved analyzing tissue samples from bladder cancer patients and comparing them with normal bladder tissue, using techniques like PCR and ELISA.

Limitations

The study did not find significant differences in mRNA expression between normal and tumor tissues, indicating variability in results.

Participant Demographics

Patients with transitional cell carcinoma (TCC) and normal bladder urothelium.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication